Lycopene modulates growth and survival associated genes in prostate cancer

Mohamed M Rafi1, Saravanan Kanakasabai, Marynell D Reyes

  • 1Department of Food Science, School of Environmental and Biological Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ08901, USA.

Insights

Lycopene, a tomato pigment, shows potential in fighting prostate cancer by affecting cell growth and survival. It modulates gene expression and enhances the effects of certain cancer therapies.

Area of Science:

  • Nutritional biochemistry
  • Cancer biology
  • Molecular oncology

Background:

  • Lycopene, a carotenoid from tomatoes, is linked to reduced prostate cancer risk.
  • The precise mechanisms of lycopene's anti-cancer effects remain unclear.
  • Prostate cancer remains a significant health concern for men worldwide.

Purpose of the Study:

  • To investigate lycopene's impact on prostate cancer cell proliferation, survival, and gene expression.
  • To explore lycopene's synergistic effects with chemotherapeutic agents and PPARγ agonists.
  • To elucidate the molecular pathways through which lycopene influences prostate cancer cells.

Main Methods:

  • Utilized WST-1 assay for proliferation studies on PC-3 prostate cancer cells.
  • Employed flow cytometry to analyze cell cycle arrest, apoptosis, and necrosis.
  • Conducted gene array and quantitative reverse transcription polymerase chain reaction (RT-qPCR) for biomarker analysis.

Main Results:

  • Lycopene exhibited a biphasic effect on PC-3 cell proliferation: increasing at low doses (1-5 μM) and decreasing at higher doses (50-100 μM).
  • Lycopene enhanced the anti-proliferative effects of Temozolomide and PPARγ agonists, but not Doxorubicin or Taxol.
  • Lycopene induced cell cycle arrest and increased apoptosis/necrosis, particularly when combined with other agents.
  • Gene expression analysis revealed lycopene's modulation of growth and apoptosis-associated biomarkers.

Conclusions:

  • Lycopene demonstrates dose-dependent effects on prostate cancer cell proliferation.
  • Lycopene potentiates the anti-cancer activity of specific chemotherapeutic agents and PPARγ agonists.
  • Lycopene attenuates prostate cancer progression by altering the expression of critical growth and survival genes.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...